-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, P5phzQjYfHP/0MHstIHESP8yD+WPfM0OTf2NQ7pp3W1ESpEitcD0XHUhW1YQRBaw 8BVQrzAdzE1A4lQMABegSw== 0000885590-10-000058.txt : 20101006 0000885590-10-000058.hdr.sgml : 20101006 20101006165010 ACCESSION NUMBER: 0000885590-10-000058 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20101004 FILED AS OF DATE: 20101006 DATE AS OF CHANGE: 20101006 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Wells William McDowall CENTRAL INDEX KEY: 0001476860 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14956 FILM NUMBER: 101112163 MAIL ADDRESS: STREET 1: OCEAN ONE, UNIT 304, MAXWELL COAST ROAD CITY: OISTINS STATE: C8 ZIP: BB17154 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Valeant Pharmaceuticals International, Inc. CENTRAL INDEX KEY: 0000885590 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A6 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 7150 MISSISSAUGA ROAD STREET 2: MISSISSAUGA CITY: ONTARIO STATE: A6 ZIP: 00000 BUSINESS PHONE: 905 286-3000 MAIL ADDRESS: STREET 1: 7150 MISSISSAUGA ROAD STREET 2: MISSISSAUGA CITY: ONTARIO STATE: A6 ZIP: 00000 FORMER COMPANY: FORMER CONFORMED NAME: BIOVAIL Corp DATE OF NAME CHANGE: 20100416 FORMER COMPANY: FORMER CONFORMED NAME: BIOVAIL CORP INTERNATIONAL DATE OF NAME CHANGE: 19960522 4 1 primary_doc.xml PRIMARY DOCUMENT X0303 4 2010-10-04 0 0000885590 Valeant Pharmaceuticals International, Inc. VRX 0001476860 Wells William McDowall 7150 MISSISSAUGA ROAD MISSISSAUGA A6 L5N 8M5 ONTARIO, CANADA 1 0 0 0 Restricted Share Units 2010-10-04 4 A 0 541 0 A 2013-01-01 2013-01-01 Common Stock, no par value 541 147997 D Restricted Share Units 2010-10-04 4 A 0 36 0 A 2012-02-25 2012-02-25 Common Stock, no par value 36 10034 D Restricted Share Units 2010-10-04 4 A 0 234 0 A 2014-08-05 2014-08-05 Common Stock, no par value 234 64161 D Restricted Share Units 2010-10-04 4 A 0 231 0 A 2015-02-17 2015-02-17 Common Stock, no par value 231 63383 D Restricted Share Units 2010-10-04 4 A 0 34 0 A 2013-02-17 2013-02-17 Common Stock, no par value 34 9506 D Deferred Share Units 2010-10-04 4 A 0 109 0 A Common Stock, no par value 109 29804 D Each Restricted Share Unit represents a contingent right to receive one share of Common Stock, no par value, of Valeant Pharmaceuticals International, Inc. (the "Common Stock"). Represents dividend equivalents accrued on Restricted Share Units as a result of a dividend paid on the Common Stock on October 4, 2010. Each Deferred Share Unit entitles its holder, upon ceasing to be a director, to receive an amount of cash having the same value as one share of Common Stock at such time. Represents dividend equivalents accrued on Deferred Share Units as a result of a dividend paid on the Common Stock on October 4, 2010. By: Angie Palmer For: William Wells 2010-10-06 -----END PRIVACY-ENHANCED MESSAGE-----